Dual-energy CT for liver iron quantification in patients with haematological disorders.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 12 06 2018
accepted: 20 09 2018
revised: 28 08 2018
pubmed: 9 11 2018
medline: 6 8 2019
entrez: 9 11 2018
Statut: ppublish

Résumé

To retrospectively quantify liver iron content in haematological patients suspected of transfusional haemosiderosis using dual-energy CT (DECT) and correlate with serum ferritin levels and estimated quantity of transfused iron. One hundred forty-seven consecutive dual-source dual-energy non-contrast chest-CTs in 110 haematologic patients intended primarily for exclusion of pulmonary infection between September 2016 and June 2017 were retrospectively evaluated. Image data was post-processed with a software prototype. After material decomposition, an iron enhancement map was created and freehand ROIs were drawn including most of the partially examined liver. The virtual iron content (VIC) was calculated and expressed in milligram/millilitre. VIC was correlated with serum ferritin and estimated amount of transfused iron. Scans of patients who had not received blood products were considered controls. Forty-eight (32.7%) cases (controls) had not received any blood transfusions whereas 67.3% had received one transfusion or more. Median serum ferritin and VIC were 138.0 μg/dl (range, 6.0-2628.0 μg/dl) and 1.33 mg/ml (range, - 0.94-7.56 mg/ml) in the post-transfusional group and 27.0 μg/dl (range, 1.0-248.0 μg/dl) and 0.61 mg/ml (range, - 2.1-2.4) in the control group. Correlation between serum ferritin and VIC was strong (r = 0.623; p < 0.001) as well as that between serum ferritin and estimated quantity of transfused iron (r = 0.681; p < 0.001). Hepatic VIC obtained via dual-energy chest-CT examinational protocol strongly correlates with serum ferritin levels and estimated amount of transfused iron and could therefore be used in the routine diagnosis for complementary evaluation of transfusional haemosiderosis. • Virtual liver iron content was measured in routine chest-CTs of haematological patients suspected of having iron overload. Chest-CTs were primarily intended for exclusion of pulmonary infection. • Measurements correlate strongly with the most widely used blood marker of iron overload serum ferritin (after exclusion of infection) and the amount of transfused iron. • Liver VIC could be used for supplemental evaluation of transfusional haemosiderosis in haematological patients.

Identifiants

pubmed: 30406312
doi: 10.1007/s00330-018-5785-4
pii: 10.1007/s00330-018-5785-4
doi:

Substances chimiques

Biomarkers 0
Iron E1UOL152H7

Types de publication

Journal Article

Langues

eng

Pagination

2868-2877

Références

Clin Chem. 1999 Mar;45(3):340-6
pubmed: 10053034
Acta Radiol. 2000 Mar;41(2):151-5
pubmed: 10741788
N Engl J Med. 2000 Aug 3;343(5):327-31
pubmed: 10922422
Blood. 2002 Jul 1;100(1):17-21
pubmed: 12070002
Invest Radiol. 1992 Apr;27(4):312-7
pubmed: 1601623
J Cardiovasc Magn Reson. 2006;8(3):543-7
pubmed: 16755844
Haematologica. 2007 Jan;92(1):131-2
pubmed: 17229649
Int J Hematol. 2008 Jul;88(1):24-29
pubmed: 18581200
Vox Sang. 2009 Oct;97(3):185-97
pubmed: 19663936
Invest Radiol. 2011 Jun;46(6):351-8
pubmed: 21263329
Eur Radiol. 2011 Aug;21(8):1727-32
pubmed: 21472472
Br J Haematol. 2011 Jun;153(6):780-5
pubmed: 21517807
Hamostaseologie. 2012;32(1):56-62
pubmed: 22008984
Radiology. 2012 Jan;262(1):126-35
pubmed: 22106352
Blood Cells Mol Dis. 2013 Jun;51(1):35-8
pubmed: 23425967
C R Biol. 2013 Mar;336(3):164-72
pubmed: 23643400
Rinsho Ketsueki. 2013 Apr;54(4):365-9
pubmed: 23666218
J Magn Reson Imaging. 2014 Nov;40(5):1003-21
pubmed: 24585403
AJR Am J Roentgenol. 2014 May;202(5):W466-74
pubmed: 24758682
Hematol Oncol Clin North Am. 2014 Aug;28(4):747-64, vii
pubmed: 25064711
Conf Proc IEEE Eng Med Biol Soc. 2014;2014:5129-32
pubmed: 25571147
Radiology. 2015 Oct;277(1):95-103
pubmed: 25880263
Pediatr Blood Cancer. 2016 May;63(5):773-80
pubmed: 26713769
Eur J Haematol. 2016 Oct;97(4):336-41
pubmed: 26800433
Radiology. 2017 Sep;284(3):706-716
pubmed: 28481195
Invest Radiol. 1982 Jul-Aug;17(4):375-80
pubmed: 7129818
J Hepatol. 1996 Aug;25(2):172-7
pubmed: 8878778
Blood. 1997 Feb 1;89(3):739-61
pubmed: 9028304

Auteurs

Sebastian Werner (S)

Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University, Hoppe-Seyler-Str.3, 72076, Tuebingen, Germany. sebastian.werner@med.uni-tuebingen.de.

Bernhard Krauss (B)

Siemens Healthcare GmbH, Diagnostic Imaging, Computed Tomography, Scanner Applications, HC DI CT R&D CTC SA, Siemensstr. 3, 91301, Forchheim, Germany.

Ulrike Haberland (U)

Siemens Healthcare Limited, HC WEA GBR DI PI, Sir William Siemens Square, Frimley, Camberley, GU16 8QD, UK.

Malte Bongers (M)

Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University, Hoppe-Seyler-Str.3, 72076, Tuebingen, Germany.

Uwe Starke (U)

Centre for Clinical Transfusion Medicine Tuebingen (ZKT), Otfried-Müller Straße 4/1, 72076, Tuebingen, Germany.

Tamam Bakchoul (T)

Transfusion Medicine, Medical Faculty of Tuebingen, Centre for Clinical Transfusion Medicine Tuebingen (ZKT), Otfried-Müller Straße 4/1, 72076, Tuebingen, Germany.

Sigrid Enkel (S)

Centre for Clinical Transfusion Medicine Tuebingen (ZKT), Otfried-Müller Straße 4/1, 72076, Tuebingen, Germany.

Konstantin Nikolaou (K)

Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University, Hoppe-Seyler-Str.3, 72076, Tuebingen, Germany.

Marius Horger (M)

Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University, Hoppe-Seyler-Str.3, 72076, Tuebingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH